| Value | ₹12.55 Cr |
|---|
BSE filing, NSE: INDRANIB. Summary written from the filing by ALFA Finder's alert engine.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹7.65
- Market cap
- ₹41.06 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 19.6×Sector 26.8×
- Promoter holding
- 32.92%-0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Board Meeting Date
Indrayani Biotech Ltd has scheduled a Board meeting for November 06, 2026. The meeting will primarily consider the notice for the company's 34th Annual General Meeting.
Indrayani Biotech Board Meeting Outcome
Indrayani Biotech appointed Ms. N. S. Poornima as Secretarial Auditor for FY 2025-26 to fill a casual vacancy. Company Secretary C.S. Shanmuga Sundar's resignation took effect on 2 November 2026.
Indrayani Biotech Legal & Regulatory
Indrayani Biotech received a tax recovery notice for outstanding demands totaling ₹1.17 Crore for various assessment years, for which the company has filed responses.
- Value
- ₹1.17 Cr
Indrayani Biotech Management Change
Independent Director Mr. K.S. Vaidyanathan has resigned from the Board of Indrayani Biotech Limited, effective October 13, 2026, due to personal reasons.
Indrayani Biotech Other Announcement
Indrayani Biotech Limited submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Indrayani Biotech Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 150.0% YoY
Indrayani Biotech Ltd reported revenue from operations of ₹37.7 Cr (+29.6% YoY) and net profit of ₹0.5 Cr (+150.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +150.0% YoY
Other capital structure change announcements
All →DCW Capital Structure Change
DCW Ltd bought back 155,000 equity shares on NSE on 03-Nov-2026 at an average price of Rs.45.18. The daily report puts the day's buyback spend at about Rs.0.70 Crore.
- Value
- ₹0.70 Cr
NCL Research and Financial Services Capital Structure Change
GCM Capital Advisors and PACs disclosed selling 8,00,000 NCL Research shares, reducing holding to 5.49%. Non-promoter transaction, no consideration stated.
Shardul Securities Capital Structure Change
Shardul Securities extinguished 1,92,00,000 equity shares bought back in its October 2026 tender offer. Post-extinguishment paid-up capital falls to Rs.1,365.84 lakhs.
JSW Dulux Capital Structure Change
HDFC Mutual Fund schemes raised their JSW Dulux stake to 8.06% via open market buying. The stake rose 2.21% as of October 30, 2026.
Carraro India Capital Structure Change
Carraro India disclosed a revised SAST Regulation 29(1) filing from 3P India Equity Fund, correcting a typo in pre-acquisition holding (26,76,588 to 26,76,558). Post-acquisition holding is 28,76,558, or 5.06%, via an open-market buy of 2,00,000 shares.
Pashupati Cotspin Capital Structure Change
Non-promoter Craft Emerging Market Fund sold 4,527,002 Pashupati Cotspin shares via open market. Holding fell from 6.42% to 3.55%.